Abstract: Methods of synthesizing sodium glucose co-transporter 2 inhibitors, as well as compounds useful therein, are disclosed. Particular inhibitors are compounds of formula I.
Type:
Grant
Filed:
August 11, 2011
Date of Patent:
October 23, 2012
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
Nicole Cathleen Goodwin, Bryce Alden Harrison, Shinya Iimura, Ross Mabon, Qiuling Song, Wenxue Wu, Jie Yan, Haiming Zhang, Matthew Mangzhu Zhao
Abstract: Solid forms of anhydrous (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol are disclosed, in addition to methods of their use in the treatment of various diseases and disorders.
Type:
Grant
Filed:
July 15, 2009
Date of Patent:
July 10, 2012
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
Susan Margaret De Paul, Anett Perlberg, Matthew Mangzhu Zhao
Abstract: Inhibitors of LIM kinase 2 are disclosed, along with pharmaceutical compositions comprising them and methods of their use.
Type:
Grant
Filed:
April 20, 2009
Date of Patent:
June 5, 2012
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
Hugh Alfred Burgoon, Nicole Cathleen Goodwin, Bryce Alden Harrison, Jason Patrick Healy, Ying Liu, Ross Mabon, Brett Marinelli, David Brent Rawlins, Dennis Stewart Rice, Norris Andrew Whitlock
Abstract: Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate and salts thereof are disclosed.
Type:
Grant
Filed:
September 25, 2008
Date of Patent:
June 5, 2012
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
Mark S. Bednarz, Susan De Paul, Ramanaiah C. Kanamarlapudi, Anett Perlberg, Haiming Zhang
Abstract: Aryl pyridines, compositions comprising them, and methods of their use for the treatment, prevention and management of a variety of diseases and disorders are disclosed.
Type:
Grant
Filed:
July 31, 2006
Date of Patent:
April 10, 2012
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
David J. Augeri, James E. Tarver, Jr., Qinghong Fu, Michael Victor Voronkov, Doan Hackley, Michael E. Mertzman, Marianne Carlsen
Abstract: Methods and compositions comprising tryptophan hydroxylase inhibitors are disclosed. Particular methods are directed at reducing or avoiding serotonin-mediated adverse effects associated with some drugs.
Abstract: 4-Amino-1H-pyrimidin-2-one-based compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of various diseases and disorders are disclosed.
Type:
Grant
Filed:
December 12, 2007
Date of Patent:
January 10, 2012
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
David J. Augeri, Marianne Carlsen, Kenneth G. Carson, Qinghong Fu, Alexander Heim-Riether, Theodore C. Jessop, James E. Tarver, Jerry A. Taylor
Abstract: O-linked pyrimidin-4-amine-based compounds, pharmaceutical compositions comprising them, and methods of their use are described.
Type:
Grant
Filed:
December 12, 2007
Date of Patent:
January 10, 2012
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
David J. Augeri, Marianne Carlsen, Kenneth G. Carson, Qinghong Fu, Jason P. Healy, Alexander Heim-Riether, Theodore C. Jessop, Philip E. Keyes, Min Shen, James E. Tarver, Jerry A. Taylor, Xiaolian Xu
Abstract: Compounds of formulae I and II are disclosed, as well as compositions comprising them and methods of their use to treat, prevent and manage serotonin-mediated diseases and disorders:
Abstract: Solid forms of (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol and hydrates thereof are disclosed, as well as compositions comprising them and methods of their use.
Type:
Grant
Filed:
June 16, 2009
Date of Patent:
August 16, 2011
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
Hugh Alfred Burgoon, Suzanne Marie Buttar, Christopher Stephen Frampton
Abstract: Methods useful for preparing compounds of formula I: and salts thereof are disclosed. Also disclosed are intermediates useful in the preparation of such compounds.
Type:
Grant
Filed:
March 26, 2010
Date of Patent:
June 28, 2011
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
Mark S. Bednarz, Hugh Alfred Burgoon, Jr., Shinya Iimura, Ramanaiah C. Kanamarlapudi, Qiuling Song, Wenxue Wu, Jie Yan, Haiming Zhang
Abstract: Compounds of formula I are disclosed, as well as compositions comprising them and methods of their use to treat, prevent and/or manage diseases and disorders:
Abstract: Methods of treating pulmonary hypertension are disclosed. Particular methods comprise the administration of a tryptophan hydroxylase inhibitor and at least one other active pharmaceutical ingredient to patient in need thereof. Pharmaceutical formulations are also disclosed.